Treatment of multiple sclerosis with anti-measles cow colostrum

Abstract

Previous virological and immunological studies have suggested that multiple sclerosis (MS) is an auto-immune disease triggered by a virus infection. In order to inhibit the growth of measles virus in the patient's jejunum, we obtained an IgA-rich cow colostrum containing anti-measles lactoglobulin resistant to proteases. This colostrum was orally administered to patients with MS to investigate its effect on the course of the disease. Measles-positive antibody colostrum was orally administered every morning to 15 patients with MS at a daily dosage of 100 ml for 30 days. Similarly, measles-negative antibody (less than 8) control colostrum was orally administered to 5 patients. As a clinical assessment, disability scores developed by the International Federation of Multiple Sclerosis Societies were used. As a result, of 7 high NT titre (512-5120) anti-measles colostrum recipients 5 patients improved and 2 remained unchanged. Among 8 low NT titre (8-32) anti-measles colostrum recipients 5 patients improved and 3 remained unchanged. However, of 5 negative NT titre (less than 8) colostrum recipients 2 patients remained unchanged and 3 worsened. No side-effects were observed in colostrum recipients. These findings suggest the efficacy of orally administered anti-measles colostrum in improving the condition of MS patients (P less than 0.05).

Reduction of BetaLactoglobulin Content of Cheese Whey by Polyphosphate Precipitation

“…Fortifying cow's milk or whey protein based formula with such biologically important proteins would improve the therapeutic value and the resistance of infants against gastrointestinal diseases. Although the benefits of feeding infants with nonimmunized lg have not yet been clearly established as they have been for feeding hyperimmunized Ig (Hilpert et al, 1974(Hilpert et al, /1975Ballabriga, 1982;Ebina et al, 1984Ebina et al, , 1985, some uses may be warranted in collaboration with other antimicrobial components in cow's milk as discussed by Packard (1982). Oral administration of human colostrum to high risk, low birth weight infants is reported to significantly reduce the rate of infection (Narayanan et al, 1983).…”